CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells

CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells

This study reports the CD44 receptor-targeted gold-doxorubicin nanocomposite (<i><sub>T</sub></i>GNC-DOX) for pulsatile chemo-photothermal therapy of triple-negative breast cancer (TNBC). The developed <i><sub>T</sub></i>GNC-DOX was nanometric, having...

Full description

Bibliographic Details
Main Authors: Dnyaneshwar Kalyane, Suryanarayana Polaka, Nupur Vasdev, Rakesh Kumar Tekade
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceutics
Subjects:
gold nanocomposite
chemo-photothermal therapy
breast cancer
CD44 receptor targeting
ROS generation
thermal ablation
Online Access:https://www.mdpi.com/1999-4923/14/12/2734

Similar Items

Similar Items